AG-13736 |
INLYTA |
AXITINIB |
AG-013736 |
AXITINIBUM |
AG 013736 |
N-METHYL-2-({3-[(E)-2-(PYRIDIN-2-YL)VINYL]-1H-INDAZOL-6-YL}SULFANYL)BENZAMIDE |
INLYTA® |
AG013736 |
drugbank:06626 |
chemidplus:319460-85-0 |
chembl:CHEMBL1289926 |
rxcui:1242999 |
pubchem.compound:6450551 |
FDA Approval | Renal cell carcinoma |
Drug Class | Kinase Inhibitors |
FDA Approval | approved |
Drug Class | Small molecule |
Drug Indications | antineoplastic agent |
Pharmaceutical Developer | Pfizer |
Pharmaceutical Developer | Novartis |
Source Reported Drug Name(s) | Axitinib/AG013736/Inlyta |
Drug Class | Kinase Inhibitor |
inhibitor (inhibitory) |
Reported Cancer Type | Prostate |
inhibitor (inhibitory) |
Reported Cancer Type | Prostate |
Mechanism of Interaction | Vascular endothelial growth factor receptor inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Reported Cancer Type | Prostate |
Direct Interaction | yes |
Mechanism of Interaction | Vascular endothelial growth factor receptor inhibitor |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Vascular endothelial growth factor receptor inhibitor |
Reported Cancer Type | Prostate |
inhibitor (inhibitory) |
Trial Name | axitinib, AG-013736 |
Novel drug target | Established target |
Reported Cancer Type | Prostate |
inhibitor (inhibitory) |
Notes | |
Trial Name | axitinib, AG-013736 |
Novel drug target | Established target |
n/a |
Trial Name | axitinib, AG-013736 |
Novel drug target | Established target |
Axitinib | PubChem Drug Name |
6450551 | PubChem Drug ID |
Inlyta | Drug Trade Name |
Drug Class | Kinase Inhibitor |
Source Reported Drug Name(s) | Axitinib/AG013736/Inlyta |
Pharmaceutical Developer | Novartis |
AG-013736 | Development Name |
AXITINIB | Generic Name |
INLYTA | Trade Name |
Drug Class | Kinase Inhibitors |
FDA Approval | Renal cell carcinoma |
Drug Indications | antineoplastic agent |
Drug Class | Small molecule |
FDA Approval | approved |
AXITINIB | Primary Drug Name |
AXITINIB | Drug Generic Name |
INLYTA | Drug Trade Name |
CHEMBL1289926 | ChEMBL Drug ID |
D01ZRI | TTD Drug ID |